14Mar 2018

TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONAY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) IN SCB MEDICAL COLLEGE, CUTTACK, ODISHA, INDIA.

  • Professor, Institute of cardiovascular sciences, Dept. of Cardiology, S.C.B.Medical College, Cuttack, Odisha, India.
  • Resident, Institute of cardiovascular sciences, Dept. of Cardiology, S.C.B.Medical College, Cuttack, Odisha, India.
  • Associate professor, Institute of cardiovascular sciences, Dept. of Cardiology, S.C.B.Medical College, Cuttack, Odisha, India.
  • Assistant professor Institute of cardiovascular sciences, Dept. of Cardiology, S.C.B.Medical College, Cuttack, Odisha, India.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Background: It has been demonstrated in previous large randomized studies that cilostazol based triple antiplatelet therapy (TAPT) in addition to aspirin and clopidogrel based dual antiplatelet therapy (DAPT) has improved the clinical outcomes in patients undergoing percutaneous coronary intervention (PCI). Objective: The present study was conducted to compare the efficacy of triple versus dual antiplatelet therapy in patients undergoing PCI. Material and methods: We enrolled 200 consecutive acute coronary syndrome patients undergoing drug eluting stents implantation. Half of the patients(n=100) received dual antiplatelet therapy (aspirin plus clopidogrel); rest half(n=100) received triple antiplatelet therapy ( aspirin, clopidogrel plus cilostazol). The triple antiplatelet group received cilostazol at least for 1 month. The two group of patients were followed up at interval of 1, 3 and 6 months for any major adverse cardiac events. The triple antiplatelet group had more bleeding manifestations than dual group. At the end of six months follow up both groups had no statistically significant difference in terms of major adverse cardiac events. Target vessel revascularization was more in in the dual than the triple antiplatelet group. Conclusions: Triple antiplatelet therapy seems to be superior to dual antiplatelet therapy in patients undergoing PCI with drug eluting stents.

  1. Aradi D, Kom?csi A, Price MJ, et al. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis. Int J Cardiol. 2012 Jun 15; (Epub ahead of print) [PubMed].
  2. Meryon I, Patel N, Millane T, Varma C. Normal coronary angiography and primary percutaneous coronary intervention for ST elevation myocardial infarction: a literature review and audit findings. Int J Clin Pract. 2010;64:1245?1251. [PubMed].
  3. Mercado N, Serruys PW et al. A meta-analytical approach for the treatment of in-stent restenosis. Eur Heart J. 2003;24:217?218.
  4. Meier B, Bachmann D, L?scher T. 25 years of coronary angioplasty: almost a fairy tale. Lancet. 2003;361:527.
  5. Mrdovic I, Savic L, Lasica R, et al. Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial. Heart Vessels. 2013;28:424?433.
  6. Gurbel PA, Tantry US. Aspirin and clopidogrel resistance: consideration and management. J Interv Cardiol. 2006;19:439?448.
  7. Laura Mauri and Deepak L. Bhatt, Braunwald?s Heart disease 10th edition, volume 2 , chapter 55 , page 1255.
  8. Serebruany VL, Steinhubl SR, Berger PBet al. Variability in platelet responsiveness to clopidogrel among 544 individuals, J Am Coll Cardiol 2005;45:246-51.
  9. Jung-Who Suh et al: Journal of the college of cardiology 2011 Jan 18;57 (3): 280-9.
  10. Lee SW, Park SW, Hong MK, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol. 2005;46:1833?1837.
  11. P. Alexannder, et al. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation, 115 (19) (2007), pp. 2549-2569.
  12. Annika Rosengren Lars Wallentin ?Anselm K. Gitt? Solomon Behar Alexander Battler? David Hasdai.? Sex, age, and clinical presentation of acute coronary syndromes European Heart Journal, Volume 25, Issue 8, 1 April 2004, Pages 663?670.
  13. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095?2128.
  14. Eagle K. Coronary artery disease in India: challenges and opportunities. Lancet. Apr 26 2008;371(9622):1394-1395.
  15. Prabhakaran D, Yusuf S, Mehta S, et al. Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2. Indian Heart J. May-Jun 2005;57(3):217-225.
  16. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998; 316:1043-7.
  17. Heart Views. 2017 Jul-Sep; 18(3): 77?82. doi: 4103/HEARTVIEWS.HEARTVIEWS_10_17
  18. Aliah Ali Khesroh et al. Gender Differences among Patients with Acute Coronary Syndrome in the Middle East. PMCID: PMC5686932.
  19. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496?501.
  20. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489?495.
  21. Ahn Y1, Jeong MH, Jeong JW, Kim KH, Ahn TH, Kang WC, Park CG, Kim JH, Chae IH, Nam CW, Hur SH, Bae JH, Kim KY, Oh SK. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. Circ J. 2008 Jan;72(1):35-9.
  22. Young-Hoon Jeong MD, PhD , Seung-WhanLeeMD, PhD :Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity: Results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) Randomized Study, Clinical Research Interventional Cardiology, Journal of the American College of Cardiology, Volume 53, Issue 13, 31 March 2009, Pages 1101-1109.
  23. Sripal Bangalore, Amita Singh, Bora Toklu , James J DiNicolantonio, Kevin Croce, Frederick Feit and Deepak L Bhatt, Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials. Heart Asia, BMJ, vol 1 , Issue 1.
  24. Seung-WhanLee, Seong-WookPark , Myeong-KiHong , Cheol WhanLee, Comparison of cilostazol and clopidogrel after successful coronary stenting,.amjcard.2004.12.012.
  25. James E. Tcheng, MD; Ing Haan Lim,Stent Parameters Predict Major Adverse Clinical Events and the Response to Platelet Glycoprotein IIb/IIIa Blockade ,Findings of the ESPRIT Trial, Cardiovasc Intervent. 2009;2:43-51.
  26. Lee CH, et al. DECREASE-PCI: Triple antiplatelet therapy reduces TVR after DES implantation. Am J Cardiol. 201;doi:10.1016/j.amjcard.2017.11.005. January 29, 2018.

[Routray S. N., Parida N. R., Patnaik U. K., Satpathy C, Mohanty N. K and Dash B. K. (2018); TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONAY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) IN SCB MEDICAL COLLEGE, CUTTACK, ODISHA, INDIA. Int. J. of Adv. Res. 6 (Mar). 1068-1074] (ISSN 2320-5407). www.journalijar.com

DR..NIIHAR RANJAN PARIDA

DOI:

Article DOI: 10.21474/IJAR01/6767      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6767

Download Full Paper

Download PDF No. of Downloads: 6 | No. of Views: 63